New Search

Your search found 44 VIDEOS, WORKSHOPS, and WEBINARS.

Article (Peer-Reviewed)

1. A Randomized Placebo-Controlled Trial of N-acetylcysteine for Cannabis Use Disorder in Adults. doc type
  Gray, Kevin M. ; Sonne, Susan C. ; McClure, Erin A. ; Ghitza, Udi E. ; Matthews, Abigail G. ; McRae-Clark, Aimee L. ; Carroll, Kathleen M. ; Potter, Jennifer Sharpe ; Wiest, Katharina ; Mooney, Larissa J. ; Hasson, Albert ; Walsh, Sharon L. ; Lofwall, Michelle R. ; Babalonis, Shanna ; Lindblad, Robert W. ; Sparenborg, Steven ; Wahle, Aimee ; King, Jacqueline S. ; Baker, Nathaniel L. ; Tomko, Rachel L. ; Haynes, Louise F. ; Vandrey, Ryan G. ; Levin, Frances R.
 Drug and Alcohol Dependence 2017 (in press). [doi: 10.1016/j.drugalcdep.2017.04.020].
 
2. Treatment Outcomes in Opioid Dependent Patients with Different Buprenorphine/Naloxone Induction Dosing Patterns and Trajectories. doc type
  Jacobs, Petra ; Ang, Alfonso ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Nielsen, Suzanne ; Wakim, Paul G. ; Mai, Barbara E. ; Mooney, Larissa J. ; Potter, Jennifer Sharpe ; Blaine, Jack D.
 American Journal on Addictions 2015;24:667-675. [doi: 10.1111/ajad.12288].
 
3. Opioid Withdrawal, Craving, and Use During and After Outpatient Buprenorphine Stabilization and Taper: A Discrete Survival and Growth Mixture Model. doc type
  Northrup, Thomas F. ; Stotts, Angela L. ; Green, Charles ; Potter, Jennifer Sharpe ; Marino, Elise N. ; Walker, N. Robrina ; Weiss, Roger D. ; Trivedi, Madhukar H.
 Addictive Behaviors 2015;41:20-28. [doi: 10.1016/j.addbeh.2014.09.021].
 
4. The Multi-Site Prescription Opioid Addiction Treatment Study: 18-Month Outcomes. doc type
  Potter, Jennifer Sharpe ; Dreifuss, Jessica A. ; Marino, Elise N. ; Provost, Scott E. ; Dodd, Dorian R. ; Rice, Lindsay S. ; Fitzmaurice, Garrett M. ; Griffin, Margaret L. ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2015;48(1):62-69. [doi: 10.1016/j.jsat.2014.07.009].
 
5. Long-term Outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Provost, Scott E. ; Fitzmaurice, Garrett M. ; McDermott, Katherine A. ; Srisarajivakul, Emily N. ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; McHugh, R. Kathryn ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2015;150:112-119. [doi: 10.1016/j.drugalcdep.2015.02.030].
 
6. Baseline Characteristics and Treatment Outcomes in Prescription Opioid Dependent Patients With and Without Co-Occurring Psychiatric Disorder. doc type
  Griffin, Margaret L. ; Dodd, Dorian R. ; Potter, Jennifer Sharpe ; Rice, Lindsay S. ; Dickinson, William ; Sparenborg, Steven ; Weiss, Roger D.
 American Journal of Drug and Alcohol Abuse 2014;40(2):157-162. [doi: 10.3109/00952990.2013.842241].
 
7. Concurrent Substance Abuse is Associated with Sexual Risk Behavior Among Adults Seeking Treatment for Prescription Opioid Dependence. doc type
  Meade, Christina S. ; Bevilacqua, Lisa A. ; Moore, Elizabeth D. ; Griffin, Margaret L. ; Gardin, John G. II ; Potter, Jennifer Sharpe ; Hatch-Maillette, Mary A. ; Weiss, Roger D.
 American Journal on Addictions 2014;23(1):27-33. [doi: 10.1111/j.1521-0391.2013.12057.x].
 
8. The Relationship Between Primary Prescription Opioid and Buprenorphine-Naloxone Induction Outcomes in a Prescription Opioid Dependent Sample. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen ; Weiss, Roger D. ; Mooney, Larissa ; Potter, Jennifer Sharpe ; Lee, Joshua ; Gourevitch, Marc N. ; Ling, Walter
 American Journal on Addictions 2014;23(4):343-348. [doi: 10.1111/j.1521-0391.2013.12105.x].
 
9. Reasons for Opioid Use Among Patients with Dependence on Prescription Opioids: The Role of Chronic Pain. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; McHugh, R. Kathryn ; Haller, Deborah L. ; Jacobs, Petra ; Gardin, John G. II ; Fischer, Daniel ; Rosen, Kristen D.
 Journal of Substance Abuse Treatment 2014;47(2):140-145. [doi: 10.1016/j.jsat.2014.03.004].
 
10. Who Benefits from Additional Drug Counseling Among Prescription Opioid Dependent Patients Receiving Buprenorphine-Naloxone and Standard Medical Management? doc type
  Weiss, Roger D. ; Griffin, Margaret L. ; Potter, Jennifer Sharpe ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; Connery, Hilary Smith ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2014;104(1):118-122. [doi: 10.1016/j.drugalcdep.2014.04.005].
 
11. Racial/Ethnic Differences in the Rates and Correlates of HIV Risk Behaviors Among Drug Abusers. doc type
  Brooks, Audrey J. ; Lokhnygina, Yuliya ; Meade, Christina S. ; Potter, Jennifer Sharpe ; Calsyn, Donald A. ; Greenfield, Shelly F.
 American Journal on Addictions 2013;22(2):136-147. [doi: 10.1111/j.1521-0391.2013.00303.x].
 
12. Patient Characteristics Associated with Buprenorphine/Naloxone Treatment Outcome for Prescription Opioid Dependence: Results from a Multisite Study. doc type
  Dreifuss, Jessica A. ; Griffin, Margaret L. ; Frost, Katherine ; Fitzmaurice, Garrett M. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Selzer, Jeffrey A. ; Hatch-Maillette, Mary A. ; Sonne, Susan C. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2013;131(1-2):112-118. [doi: 10.1016/j.drugalcdep.2012.12.010].
 
13. Gender Differences in a Clinical Trial for Prescription Opioid Dependence. doc type
  McHugh, R. Kathryn ; DeVito, Elise E. ; Dodd, Dorian ; Carroll, Kathleen M. ; Potter, Jennifer Sharpe ; Greenfield, Shelly F. ; Connery, Hilary Smith ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2013;45(1):38-43. [doi: 10.1016/j.jsat.2012.12.007].
 
14. Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings from Starting Treatment with Agonist Replacement Therapies (START). doc type
  Potter, Jennifer Sharpe ; Marino, Elise N. ; Hillhouse, Maureen P. ; Nielsen, Suzanne ; Wiest, Katharina ; Canamar, Catherine P. ; Martin, Judith A. ; Ang, Alfonso ; Baker, Rachel ; Saxon, Andrew J. ; Ling, Walter
 Journal of Studies on Alcohol and Drugs 2013;74(4):605-613..
 
15. Randomized Multi-site Trial of the Job Seekers' Workshop in Patients with Substance Use Disorders. doc type doc type
  Svikis, Dace S. ; Keyser-Marcus, Lori ; Stitzer, Maxine L. ; Rieckmann, Traci R. ; Safford, Lauretta ; Loeb, Peter ; Allen, Tim ; Luna-Anderson, Carol ; Back, Sudie E. ; Cohen, Judith ; DeBernardi, Michael A. ; Dillard, Bruce ; Forcehimes, Alyssa A. ; Jaffee, William B. ; Killeen, Therese ; Kolodner, Ken B. ; Levy, Michael S. ; Pallas, Diane ; Perl, Harold I. ; Potter, Jennifer Sharpe ; Provost, Scott E. ; Reese, Karen ; Sampson, Royce ; Sepulveda, Allison ; Snead, Ned ; Wong, Conrad J. ; Zweben, Joan E.
 Drug and Alcohol Dependence 2012;120(1-3):55-64. [doi: 10.1016/j.drugalcdep.2011.06.024].
 
16. Predictors of Attrition with Buprenorphine/Naloxone Treatment in Opioid Dependent Youth. doc type
  Warden, Diane ; Subramaniam, Geetha A. ; Carmody, Thomas ; Woody, George E. ; Minhajuddin, Abu T. ; Poole, Sabrina A. ; Potter, Jennifer Sharpe ; Fishman, Marc J. ; Bogenschutz, Michael P. ; Patkar, Ashwin A. ; Trivedi, Madhukar H.
 Addictive Behaviors 2012;37(9):1046-1053. [doi: 10.1016/j.addbeh.2012.04.011].
 
17. Site Selection in Community-Based Clinical Trials for Substance Use Disorders: Strategies for Effective Site Selection. doc type
  Potter, Jennifer Sharpe ; Donovan, Dennis M. ; Weiss, Roger D. ; Gardin, John G. II ; Lindblad, Robert ; Wakim, Paul G. ; Dodd, Dorian R.
 American Journal of Drug and Alcohol Abuse 2011;37(5):400-407. [doi: 10.3109/00952990.2011.596975].
 
18. Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth. doc type
  Subramaniam, Geetha A. ; Warden, Diane ; Minhajuddin, Abu T. ; Fishman, Marc J. ; Stitzer, Maxine L. ; Adinoff, Bryon H. ; Trivedi, Madhukar H. ; Weiss, Roger D. ; Potter, Jennifer Sharpe ; Poole, Sabrina A. ; Woody, George E.
 Journal of the American Academy of Child & Adolescent Psychiatry 2011;50(11):1120-1128. [doi: 10.1016/j.jaac.2011.07.010].
 
19. Determining the Primary Endpoint for a Stimulant Abuse Trial: Lessons Learned from STRIDE (CTN 0037). doc type
  Trivedi, Madhukar H. ; Greer, Tracy L. ; Potter, Jennifer Sharpe ; Grannemann, Bruce D. ; Nunes, Edward V. ; Rethorst, Chad ; Warden, Diane ; Ring, Kolette M. ; Somoza, Eugene C.
 American Journal of Drug and Alcohol Abuse 2011;37(5):339-349. [doi: 10.3109/00952990.2011.598589].
 
20. Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial. doc type doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Byrne, Mimmie ; Connery, Hilary Smith ; Dickinson, William ; Gardin, John G. II ; Griffin, Margaret L. ; Gourevitch, Marc N. ; Haller, Deborah L. ; Hasson, Albert L. ; Huang, Zhen ; Jacobs, Petra ; Kosinski, Andrzej S. ; Lindblad, Robert ; McCance-Katz, Elinore F. ; Provost, Scott E. ; Selzer, Jeffrey A. ; Somoza, Eugene C. ; Sonne, Susan C. ; Ling, Walter
 Archives of General Psychiatry 2011;68(12):1238-1246. [doi: 10.1001/archgenpsychiatry.2011.121].
 
21. Gender Differences in the Rates and and Correlates of HIV Risk Behaviors Among Drug Abusers. doc type
  Brooks, Audrey J. ; Meade, Christina S. ; Potter, Jennifer Sharpe ; Lokhnygina, Yuliya ; Calsyn, Donald A. ; Greenfield, Shelly F.
 Substance Use & Misuse 2010;45(14):2444-2469. [doi: 10.3109/10826084.2010.490928].
 
22. A Method to Diagnose Opioid Dependence Resulting from Heroin Versus Prescription Opioids Using the Composite International Diagnostic Interview. doc type
  Potter, Jennifer Sharpe ; Prather, Kristi ; Kropp, Frankie B. ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Mohamedi, Nadia ; Copersino, Marc L. ; Weiss, Roger D.
 Contemporary Clinical Trials 2010;31(2):185-188. [doi: 10.1016/j.cct.2010.01.002].
 
23. Pain and Continued Opioid Use in Individuals Receiving Buprenorphine-Naloxone for Opioid Detoxification: Secondary Analyes from the Clinical Trials Network. doc type
  Potter, Jennifer Sharpe ; Chakrabarti, Amit ; Domier, Catherine P. ; Hillhouse, Maureen P. ; Weiss, Roger D. ; Ling, Walter
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S80-S86. [doi: 10.1016/j.jsat.2009.12.007].
 
24. Alterations in Brain Structure and Functional Connectivity in Prescription Opioid-Dependent Patients. doc type
  Upadhyay, Jaymin ; Maleki, Nasim ; Potter, Jennifer Sharpe ; Elman, Igor ; Rudrauf, David ; Knudsen, Jaime ; Wallin, Diane ; Pendse, Gautam ; McDonald, Leah ; Griffin, Margaret L. ; Anderson, Julie ; Nutile, Lauren ; Renshaw, Perry ; Weiss, Roger D. ; Becerra, Lino ; Borsook, David
 Brain 2010;133(7):2098-2114. [doi: 10.1093/brain/awq138].
 
25. Conducting Clinical Research with Prescription Opioid Dependence: Defining the Population. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Copersino, Marc L. ; Prather, Kristi ; Jacobs, Petra ; Provost, Scott E. ; Chim, David ; Selzer, Jeffrey A. ; Ling, Walter
 American Journal on Addictions 2010;19(2):141-146. [doi: 10.1111/j.1521-0391.2009.00017.x].
 
26. A Multi-Site, Two-Phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, Design, and Methodology. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Provost, Scott E. ; Huang, Zhen ; Jacobs, Petra ; Hasson, Albert L. ; Lindblad, Robert ; Connery, Hilary Smith ; Prather, Kristi ; Ling, Walter
 Contemporary Clinical Trials 2010;31(2):189-199. [doi: 10.1016/j.cct.2010.01.003].
 
27. Extended vs. Short-Term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth: A Randomized Trial. doc type doc type
  Woody, George E. ; Poole, Sabrina A. ; Subramaniam, Geetha A. ; Dugosh, Karen L. ; Bogenschutz, Michael P. ; Abbott, Patrick J. ; Patkar, Ashwin A. ; Publicker, Mark ; McCain, Karen ; Potter, Jennifer Sharpe ; Forman, Robert F. ; Vetter, Victoria ; McNicholas, Laura F. ; Blaine, Jack D. ; Lynch, Kevin G. ; Fudala, Paul
 JAMA 2008;300(17):2003-2011. [doi: 10.1001/jama.2008.574].
 
28. A Feasibility Study of a Web-Based Performance Improvement System for Substance Abuse Treatment Providers. doc type doc type
  Forman, Robert F. ; Crits-Christoph, Paul ; Kaynak, Ovgu ; Worley, Matt ; Hantula, Donald A. ; Kulaga, Agatha ; Rotrosen, John ; Chu, Melissa ; Gallop, Robert ; Potter, Jennifer Sharpe ; Muchowski, Patrice ; Brower, Kirk ; Strobbe, Stephen ; Magruder, Kathryn M. ; Chellis, A'Delle H. ; Clodfelter, Tad ; Cawley, Margaret
 Journal of Substance Abuse Treatment 2007;33(4):363-371. [doi: 10.1016/j.jsat.2007.01.007].
 

Manual

29. Patient Feedback Manual, Version 1.0 doc type
  Forman, Robert F. ; Krejci, Jonathan ; Selzer, Jeffrey A. ; Hantula, Donald A. ; Potter, Jennifer Sharpe ; Brower, Kirk ; Grissom, Grant ; Arfken, Cynthia L. ; Scruton, Theresa
 Philadelphia, PA: University of Pennsylvania, Treatment Research Institute, 2003.
 

Poster

30. Changes in Quality of Life in Cocaine-Dependent Participants Provided Treatment with Buprenorphine+Naloxone Combined with Extended Release Naltrexone. doc type
  Shmueli-Blumberg, Dikla ; Carrizales, Fermin A. ; Kazanis, William H. ; Hillhouse, Maureen ; Matthews, Abigail ; Potter, Jennifer Sharpe
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
31. Opioid Withdrawal and Craving Trajectories Following Buprenorphine Taper: A Latent Class and Growth Mixture Model of Time-to-First Opioid Lapse. doc type
  Northrup, Thomas F. ; Stotts, Angela L. ; Green, Charles ; Potter, Jennifer Sharpe ; Marino, Elise N. ; Weiss, Roger D. ; Mulpur, Swetha ; Walker, N. Robrina ; Trivedi, Madhukar H.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
32. Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Connery, Hilary Smith ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Hollywood, FL, June 18-23, 2011.
 
33. A Community-Based, Two-Phase Randomized Controlled Trial of Buprenorphine With and Without Individual Drug Counseling for the Treatment of Opioid Analgesic Addiction. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D. ; Jacobs, Petra ; Ling, Walter
 Poster presented at the American Public Health Association (APHA) Annual Meeting, Denver, CO, November 6-10, 2010..
 
34. Use of an Adaptive Treatment Research Design in a CTN Study of Prescription Opioid Dependence Treatment. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 

Presentation

35. Advances in Clinical Research for Prescription Opioid Dependence. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D.
 Presented at the National Association of Social Workers Massachusetts Chapter Symposium, Framingham, MA, March 29-30, 2012.
 
36. Gender Differences in Rates and Correlates of HIV Risk Behaviors Among Drug Dependent Individuals. doc type
  CTN Gender Special Interest Group ; Brooks, Audrey J. ; Meade, Christina S. ; Potter, Jennifer Sharpe ; Lokhnygina, Yuliya ; Calsyn, Donald A. ; Greenfield, Shelly F.
 Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 

Video

37. 2012 Texas Research to Practice Conference: Learn how Science is Impacting Addiction Treatment. doc type doc type doc type
  Trivedi, Madhukar H. ; Crowell, A. Rebecca ; Denton, Douglas ; Kosten, Thomas ; Potter, Jennifer Sharpe ; Hien, Denise A. ; Spence, Richard ; Levy, Michael S. ; Muir, Joan A.
 Dissemination Conference sponsored by the Texas Node, Dallas, TX, April 30, 2012.
 

Webinar

38. CTN Webinar: Adaptive Research Design for Substance Abuse Clinical Trials. doc type
  Wiest, Katharina ; Potter, Jennifer Sharpe
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, October 23, 2013.
 
39. CTN Webinar: Site Selection Strategies in Substance Abuse Research. doc type
  Potter, Jennifer Sharpe ; Rothwell, Ro Shauna
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, February 8, 2012.
 
40. CTN Webinar: Helping Patients with Substance Use Disorders and Pain. doc type
  Potter, Jennifer Sharpe ; Weiss, Roger D.
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, December 19, 2012.
 
41. CTN Webinar: Informed Consent for Human Participant Research. doc type
  Kunkel, Lynn E. ; Potter, Jennifer Sharpe
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, July 24, 2008.
 
42. CTN Webinar: Recruitment and Retention. doc type
  Kunkel, Lynn E. ; Potter, Jennifer Sharpe
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, June 18, 2008.
 
43. CTN Webinar: Good Clinical Practice. doc type
  Potter, Jennifer Sharpe
 Produced by the National Drug Abuse Treatment Clinical Trials Network's Clinical Coordinating Center, October 14, 2008.
 

Workshop

44. 2012 Texas Research to Practice Conference: Learn how Science is Impacting Addiction Treatment. doc type doc type doc type
  Trivedi, Madhukar H. ; Crowell, A. Rebecca ; Denton, Douglas ; Kosten, Thomas ; Potter, Jennifer Sharpe ; Hien, Denise A. ; Spence, Richard ; Levy, Michael S. ; Muir, Joan A.
 Dissemination Conference sponsored by the Texas Node, Dallas, TX, April 30, 2012.